Mark von Itzstein
Corporate Officer/Principal at Deakin University
Profile
Mark von Itzstein is the founder of Glykoz Pharma Discovery Pty Ltd., which was founded in 2002, where he held the title of Board Member & Research Director.
He currently holds a position as a Member at Deakin University.
He formerly held a position as a Member at Meditech Research Ltd.
Mark von Itzstein active positions
| Companies | Position | Start |
|---|---|---|
| Deakin University | Corporate Officer/Principal | - |
Former positions of Mark von Itzstein
| Companies | Position | End |
|---|---|---|
Meditech Research Ltd.
 Meditech Research Ltd. BiotechnologyHealth Technology Meditech was an Australian biotechnology company focusing on the development of carbohydrate-based therapeutics. The company's platform technology HyACT™ was a drug-delivery technology shown to be highly effective in treating a variety of cancer types. The company was Located in Victoria, Australia. | Corporate Officer/Principal | - |
Glykoz Pharma Discovery Pty Ltd.
 Glykoz Pharma Discovery Pty Ltd. Pharmaceuticals: MajorHealth Technology Glykoz Pharma Discovery Pty Ltd. develops carbohydrate based drugs. It also develops drug candidates for licensing to international biotechnology and pharmaceutical companies. The company was founded by Andrew Loch, Ross Coppel, Karyn Joyner, Mark von Itzstein and Richard J. McElhinney on 5 December, 2006 and is headquartered in Nerang, Australia. | Founder | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
Glykoz Pharma Discovery Pty Ltd.
Glykoz Pharma Discovery Pty Ltd. Pharmaceuticals: MajorHealth Technology Glykoz Pharma Discovery Pty Ltd. develops carbohydrate based drugs. It also develops drug candidates for licensing to international biotechnology and pharmaceutical companies. The company was founded by Andrew Loch, Ross Coppel, Karyn Joyner, Mark von Itzstein and Richard J. McElhinney on 5 December, 2006 and is headquartered in Nerang, Australia. | Health Technology |
Meditech Research Ltd.
Meditech Research Ltd. BiotechnologyHealth Technology Meditech was an Australian biotechnology company focusing on the development of carbohydrate-based therapeutics. The company's platform technology HyACT™ was a drug-delivery technology shown to be highly effective in treating a variety of cancer types. The company was Located in Victoria, Australia. | Health Technology |
- Stock Market
- Insiders
- Mark von Itzstein
